Hervé Germain
AstraZeneca (France)(FR)
Publications by Year
Research Areas
Quinazolinone synthesis and applications, Chemical Synthesis and Analysis, Synthesis and Characterization of Heterocyclic Compounds, Catalytic Cross-Coupling Reactions, Click Chemistry and Applications
Most-Cited Works
- → Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors(2006)92 cited
- → Discovery of 1-(4-(5-(5-amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one (AZD8835): A potent and selective inhibitor of PI3Kα and PI3Kδ for the treatment of cancers(2015)35 cited
- → New heterocyclic analogues of 4-(2-chloro-5-methoxyanilino)quinazolines as potent and selective c-Src kinase inhibitors(2005)28 cited
- → A versatile route to 3-(pyrimidin-4-yl)-imidazo[1,2-a]pyridines and 3-(pyrimidin-4-yl)-pyrazolo[1,5-a]pyridines(2010)19 cited
- → A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase(2007)18 cited
- → Facile, diversity-orientated one-pot synthesis of ethyl 1,5-disubstituted-1H-1,2,4-triazole-3-carboxylates(2012)12 cited
- → Neutral 5-substituted 4-indazolylaminoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase(2008)10 cited
- → Structure–activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: Part 1(2012)9 cited
- → Structure–activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: Part 2(2012)9 cited
- → Facile preparation and Suzuki–Miyaura cross-coupling of N-2-alkylated 2H-1,2,3-triazole 4-boronates(2012)9 cited